Telix Pharmaceuticals | TLX - Assets


Telix Pharmaceuticals reported AUD1.36B in Assets for its fiscal semester ending in June of 2026.





Assets Change Date
Cochlear AUD 2.79B 31.3M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Integral Diagnostics AUD 744.28M 1.52M Jun/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Mesoblast USD 773.08M 9.23M Jun/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Pacific Edge NZD 17.6M 17.06M Jun/2026
Paradigm Biopharmaceuticals AUD 23.15M 1.42M Dec/2025
Polynovo AUD 123.37M 4.04M Dec/2025
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
ResMed USD 8.78B 280.91M Mar/2026
Sonic Healthcare AUD 15.38B 550.57M Dec/2024